Schoolchildren from 2 areas of Kenya, Kangundo and Kambu, have contrasting prevalences of hepatosplenomegaly, despite having similar prevalences and intensities of Schistosoma mansoni infection. However, in individual children, S. mansoni infection intensity is positively correlated with organomegaly. In a previous study, hepatosplenomegaly was associated with Th1-type antischistosome cytokine responses. Although the high-morbidity Kambu area had higher malaria transmission than did low-morbidity Kangundo, hepatosplenomegaly was not associated with clinical malaria or with patent malarial parasitemia. However, chronic exposure to malaria might be involved. Here, retrospectively, we assayed plasma from this original study, for anti-Plasmodium falciparum and anti-S. mansoni antibodies, to test whether greater exposure to Plasmodium was a cofactor for hepatosplenomegaly. We found that hepatosplenic children had significantly higher levels of anti-P. falciparum antibodies, compared with nonhepatosplenic children, a finding that strongly suggests that some experience of P. falciparum influenced the development of hepatosplenomegaly in these S. mansoni-infected children.
japonicum infection. HS is characterized by hepatosplenomegaly and by increased portal venous pressure that can lead to ascites and esophagogastric varices, which can result in sometimes-fatal hematemesis. Adult S. mansoni worms live in the intestinal mesenteric blood capillaries, and it is thought, by extrapolation from murine models, that HS results from host responses to parasite eggs that, failing to pass into the intestinal lumen, are carried to and lodge in hepatic capillary beds. In autopsy studies, of schistosomiasis case subjects in Brazil [1] , hepatosplenomegaly and signs of portal hypertension were invariably associated with Symmer pipe-stem fibrosis, and not with lesser lesions, such as fibrosis of small portal tracts or of inflammatory infiltrates. Symmer fibrosis is characterized by macroscopic fibrosis of the portal vein branches, which can now be visualized by ultrasonography. In areas in which schistosomiasis is endemic, peak infection intensities occur in late childhood, whereas most Symmer fibrosis is found in older individuals. Thus, although hepatic fibrosis is more prevalent in areas in which transmission of schistosomiasis is high, individuals suffering from HS with Symmer fibrosis often, at the time of diagnosis, either (1) have low infection intensities or (2) no longer have detectable infection. However, in many areas of sub-Saharan Africa, where most cases of human schistosomiasis occur, schistosomiasis-associated hepatomegaly and hepatosplenomegaly have long been reported to occur in schoolaged children, with the age of peak prevalence coinciding with the age of highest intensity of infection [2, 3] , in areas where S. mansoni transmission has been reported to be high [2] .
We have previously reported that schoolchildren in 2 areas of the Machakos District of Kenya, Kambu (now in Makueni District) and Kangundo, both of which are populated by the Kamba people, have very different prevalences of hepatosplenomegaly, despite having similar prevalences and intensities of S. mansoni infection [4, 5] . In both areas, hepatosplenomegaly, as characterized by chronic organomegaly with a firm/hard consistency, increases with intensities of S. mansoni infection. Studies of schoolchildren showed that !1% of infected children in KanInformed consent was obtained from the parents or legal guardians of all children who participated in this study, in line with the national guidelines of the Kenyan Medical Research Institute, whose ethical review committee approved all the protocols used, and in line with the guidelines of the US Department of Health and Human Services. gundo had palpable hepatosplenomegaly, compared with 120% of infected children in Kambu [6, 7, 8] . In Kambu children, organomegaly was frequently massive, and, when examined by endoscopy, 18 (40%) of 45 children with severe organomegaly were found to have esophageal varices. In some of these children, in contrast to the results in the Brazilian autopsy study [1] , varices were reported with little or no concurrent hepatic portal fibrosis detectable by ultrasonography.
These observations suggest that environmental factors are influencing the prevalence of hepatosplenomegaly among schistosome-infected schoolchildren in different areas of Kenya. Differences in parasite strains, patterns of exposure, host nutritional status, and exposure to other infectious or toxic agents-such as S. haematobium, hookworm, Ascaris, Trichuris, Enterobius, Entamoeba histolytica, Entamoeba coli, Giardia lamblia, Brucella abortus, and malaria-have been investigated but have not been found to explain the differences, in organomegaly prevalence, between Kangundo children and Kambu children [6, 8, 9] . Of the infectious agents, only malaria has been found to be more prevalent in Kambu children [6, 9] , but no association with patent malaria has been found. However, some aspect of chronic exposure to malaria remains as a possible cofactor associated with the high prevalence of organomegaly in S. mansoni-infected Kambu children [6] .
In a case-control study of specific anti-schistosome immune responses and hepatosplenomegaly in Kambu children and Kangundo children, peripheral blood mononuclear cells from hepatosplenic case subjects responded to schistosome egg and worm antigens with significantly higher interferon-g (IFN-g) and tumor necrosis factor (TNF), but with lower interleukin-5 (IL-5), compared with nonhepatosplenic control subjects [10] . Hepatosplenomegaly was also associated with high levels of circulating soluble TNF receptors 1 and 2 and of sICAM-1, all of which correlated negatively with IL-5 and positively with IFN-g. This pattern of schistosome-specific T helper type-1 responses contrasts with the T helper type-2 responses usually associated with schistosomiasis. Again, hepatosplenomegaly was not associated with either clinical malaria or malarial parasitemia, in this study. Malaria in Kambu schoolchildren, although relatively high, is seasonal, and the study was carried out during the dry season, when patent parasitemia is uncommon. Therefore, the possibility remains that either chronic exposure to malaria or chronic asymptomatic and subpatent malarial infection is a cofactor.
Anti-S. mansoni IgG3 is also associated with hepatosplenomegaly in Kambu children [11] , and we have recently shown that this anti-schistosome response cross-reacts with Plasmodium falciparum antigens [12] . Here, we have retrospectively assayed plasma from the Kambu/Kangundo case-control study [10] , for anti-P. falciparum schizont (Pfs) and anti-S. mansoni antibodies, to assess whether or not they provide evidence that exposure to Plasmodium may be a factor in the development of hepatosplenomegaly in S. mansoni-infected children.
Subjects, materials, and methods. Plasma samples used here were the same as those described by Mwatha et al. [10] . All children were from the Kamba ethnic group and were living in either Kambu or Kangundo. The 2 areas had comparable prevalences and intensities of moderate schistosomiasis mansoni; however, malaria was more prevalent in Kambu children (described in [6] ). Three groups of S. mansoni-infected children (8-16 years old) matched for age ‫ע(‬ 1 year) and for infection intensity ‫ע(‬ 10% fecal egg count) were selected on the basis of palpable liver and spleen size, as follows: (1) Kangundo (lowhepatosplenomegaly area)-out-of-area nonhepatosplenomegaly control subjects; (2) Kambu (high-hepatosplenomegaly area)-in-area nonhepatosplenomegaly control subjects; and (3) Kambu-hepatosplenomegaly case subjects. Hepatosplenomegaly, assessed by palpation, was defined as the presence of both liver and spleen enlargement, of у2 cm, with a firm/hard consistency. Neither organ was palpable in the control subjects [10] . Blood sampling was performed simultaneously for the 2 control groups and the case group. Plasma was separated, was aliquoted, and was stored at Ϫ80ЊC. Antigen preparation, IgG1 and IgG3 anti-S. mansoni soluble adult worm (SWA) and soluble egg (SEA), and Pfs ELISA were as described elsewhere [12] .
Results. When all 3 morbidity groups were analyzed as a single cohort ( When the relationships between different responses were examined within each of the 3 morbidity groups separately, different relationships were found in the Kangundo group, compared with the 2 Kambu groups (table 1). In low-morbidity/ low-malaria Kangundo, the strongest correlations were between the various anti-S. mansoni responses. Anti-Pfs responses were low and were not significantly correlated with responses to S. mansoni. In contrast, in both Kambu groups, correlations between the different anti-S. mansoni responses were much lower or absent (the only correlation 10.5 was between SWA IgG3 and SEA IgG3). However, strong correlations were found between Pfs IgG1 and Pfs IgG3 and also between Pfs IgG3, SWA IgG3, and SEA IgG3. The correlation between anti-Pfs IgG3 and anti-SWA IgG3 was particularly strong and significant ( ). These findings suggest that, in malaria-endemic P ! .0033 Kambu, anti-schistosome responses, especially those of the IgG3 type, are influenced by responses to cross-reactive P. fal- ciparum epitopes, a situation seen in other schistosomiasis/ malaria-coendemic areas, in Kenya, in Uganda, and in Sudan [12] .
Median IgG1 and IgG3 responses to SEA, SWA, and Pfs are shown in figure 1 . The Mann-Whitney U test was used to assess whether differences between groups were statistically significant ( [Bonferroni correction]). No significant differ-P ! .0166 ence was observed, between any of the groups, for anti-SEA IgG1. Anti-SWA IgG1 was significantly higher in the Kambu case group, compared with the Kangundo control group (P ! ) but did not differ significantly from that in the Kambu .001 control group ( ). As might be expected, anti-Pfs IgG1 P ! .092 responses were higher in the 2 Kambu groups than in the Kangundo group. However, anti-Pfs IgG1 levels were also significantly higher in the Kambu case group, compared with the Kambu control group ( for all). P ! .001 A similar but more marked pattern was seen for IgG3 antibodies. Anti-SEA IgG3 was significantly higher in the Kambu case group than in either the Kangundo control group or the Kambu control group ( and , respectively), but P ! .005 P ! .001 it did not differ between the 2 control groups. Anti-SWA IgG3 was also significantly higher in the Kambu case group than in either the Kangundo control group or the Kambu control group ( for both), but it did not differ between the 2 control P ! .001 groups. Anti-Pfs IgG3 was markedly higher in the Kambu case group than in either the Kangundo control group or the Kambu control group, and, between control groups, it was higher in the Kambu group ( for all). P ! .001 Discussion. We have hypothesized that the high prevalence of hepatosplenomegaly in S. mansoni-infected schoolchildren in Kambu, compared with S. mansoni-infected schoolchildren in Kangundo, might be associated with higher exposure to malaria. As expected, anti-malarial antibody responses were generally higher in Kambu schoolchildren than in Kangundo schoolchildren. Whereas anti-SEA responses were similar in schoolchildren from the 2 areas, anti-SWA IgG1 and SEA IgG3 responses were higher in Kambu schoolchildren, even though the groups were matched for intensity of S. mansoni infection. One explanation for the differences in anti-SWA responses would be that, in Kambu schoolchildren, these responses, particularly anti-SWA IgG3, were driven by cross-reactive P. falciparum epitopes [12] . This explanation is supported by the very high correlation both between anti-SWA IgG1 and anti-Pfs IgG1 and, especially, anti-SWA IgG3 and anti-Pfs IgG3 responses, in the 2 groups from the Kambu area, where malaria transmission is relatively high.
However, the most interesting observation in this study is the difference, in anti-malaria (and cross-reactive anti-SWA) antibody responses, between Kambu case subjects and Kambu control subjects: hepatosplenic case subjects had markedly higher anti-malaria IgG1 and IgG3 responses than did control subjects. Thus, the possession of anti-malarial antibodies appears to be a major risk factor for the development of hepatosplenomegaly in schistosome-infected schoolchildren who live in this coendemic area; or, alternatively, hepatosplenomegaly-or the genetic propensity to develop this condition-promotes IgG3 production in some way.
In Zairian villages that had similar prevalences of malaria but different prevalences of S. mansoni transmission [2] , a 26% overall prevalence of hepatosplenomegaly (highest in 6-18-year-olds) was found where S. mansoni transmission was high; organomegaly was much lower where transmission was low. In the same study, hepatomegaly positively correlated with high intensities of schistosomiasis in children but not in adults. The authors of that study speculated that perhaps organomegaly in adults, but not in children, was associated with Symmer fibrosis. We have extensive unpublished data (B. Vennervald, personal communication), from clinical and ultrasound examinations of adult and childhood schistosomiasis-associated hepatosplenomegaly in Uganda and Kenya, that confirm the observations and speculations of the Zairian study [2] . An earlier study, in a schistosomiasis/malaria-coendemic area in Zimbabwe (then Rhodesia), had shown that hepatomegaly in 0-4-year-old children was significantly associated with patent malaria. However, in 5-9-yearold children, hepatomegaly was not significantly associated with malaria but was associated with either S. mansoni infection or combined S. mansoni/malaria infection [13] . It is thought that both schistosomiasis and malaria affect the age profiles for hepatosplenomegaly in communities in coendemic areas [14] . The data reported by the present study suggest that some aspect of exposure to malaria influences the development of hepatosplenomegaly in schistosomiasis-infected children in parts of Kenya. This form of hepatosplenomegaly does not depend on either acute clinical malaria or patent malaria parasitemia; however, chronic exposure to plasmodium infection or chronic subpatent malaria infection may be involved.
Both schistosomiasis mansoni and malaria, individually, adversely affect the liver. Malaria-associated hepatosplenomegaly is most often found in children !5 years old and is often characterized by a soft organomegaly that, with successful chemotherapy, rapidly regresses [15] . In schistosomiasis-endemic areas, hepatosplenomegaly that is characterized by firm/hard organ consistency peaks in late childhood, at the age of greatest S. mansoni infection intensities [2, 3, 13] . Indeed, among the larger school population from which the Kambu case/control subjects were selected for this study, S. mansoni infection intensity positively correlated with the degree of hepatosplenomegaly (L. Kenty, personal communication). S. mansoni and P. falciparum have overlapping distributions in many parts of sub-Saharan Africa, and, in coendemic areas, repeated and chronic infections with both parasites ensure that concurrent infections are common. Interactions between these 2 infections could provide some explanation for the widespread but uneven distribution of childhood schistosomiasis-associated hepatosplenomegaly reported in these areas. It is not clear from this study whether this interaction is due to concomitant infection with both parasites (with malaria infection being indicated by higher levels of anti-malaria antibody) or whether qualitative and quantitative differences in antischistosome immune responses, perhaps resulting from earlychildhood malaria, might affect the outcome of subsequent schistosome infections. Therefore, the significance of the association between anti-schistosome T helper type-1 cytokine responses, perhaps influenced by malaria, and this form of hepatosplenomegaly [10] remains an important question, as does the impact of this morbidity on child health and the impact of morbidity's relationship to the development of hepatic portal fibrosis.
